Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 32,684 shares at $241.78 ($7.9M) on 2020-02-18, disclosed to the SEC on 2020-02-19.
Seasonal sale ($7.9M) by CEO & President — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.50 | 9,314 | $2.2M | 28.3% |
| 2 | $241.78 | 1,680 | $406K | 5.1% |
| 3 | $241.78 | 1,680 | $406K | 5.1% |
| 4 | $242.61 | 4,241 | $1.0M | 13.0% |
| 5 | $242.61 | 4,241 | $1.0M | 13.0% |
| 6 | $243.65 | 1,971 |
| $480K |
| 6.0% |
| 7 | $243.65 | 1,971 | $480K | 6.0% |
| 8 | $244.87 | 2,030 | $497K | 6.3% |
| 9 | $244.87 | 2,030 | $497K | 6.3% |
| 10 | $245.66 | 1,763 | $433K | 5.5% |
| 11 | $245.66 | 1,763 | $433K | 5.5% |
| Total | $242.94 avg | 32,684 | $7.9M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |